Cancer Center Overview

The Albert Einstein Cancer Center (AECC) was established in 1971 and was among the first academic cancer research centers to be funded by the National Cancer Institute, a designation continuously held since 1972. Today AECC draws upon the talent of over 150 members from 20 academic departments at the Albert Einstein College of Medicine to foster basic, clinical, population, and translational research in an effort to better understand the origins of cancer and its effective detection, prevention, and treatment.

The mission of Albert Einstein Cancer Center is to reduce the burden of cancer in the Bronx and the nation through paradigm-shifting, practice-changing, and policy-impacting cancer-focused research, education and training of a diverse workforce, and community outreach and engagement with delivery of compassionate state-of-the-art care for all, including communities that face heightened disparities in cancer and social determinants of health.

AECC’s cancer research programs are supported by 12 specialized Shared Resource facilities that provide technologies and services spanning laboratory, population, and clinical research.

Clinical research studies and clinical trials are available at our Cancer Center within the context of multidisciplinary disease-focused teams. A comprehensive portfolio of clinical trials are offered to study the prevention, early detection and treatment for a wide spectrum of cancers. The Cancer Clinical Trials Office provides services for protocol development, regulatory affairs, and data management.